Semler Scientific, Inc. (NASDAQ:SMLR) Shares Acquired by Legal & General Group Plc

Legal & General Group Plc increased its stake in shares of Semler Scientific, Inc. (NASDAQ:SMLR) by 65.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,056 shares of the company’s stock after purchasing an additional 813 shares during the quarter. Legal & General Group Plc’s holdings in Semler Scientific were worth $111,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the company. Global Retirement Partners LLC raised its holdings in Semler Scientific by 62.5% during the fourth quarter. Global Retirement Partners LLC now owns 1,300 shares of the company’s stock worth $70,000 after purchasing an additional 500 shares in the last quarter. Sanctuary Advisors LLC raised its stake in shares of Semler Scientific by 13.2% during the 4th quarter. Sanctuary Advisors LLC now owns 5,012 shares of the company’s stock worth $261,000 after buying an additional 584 shares in the last quarter. Jones Financial Companies Lllp acquired a new stake in shares of Semler Scientific in the 4th quarter valued at approximately $34,000. Larson Financial Group LLC purchased a new stake in shares of Semler Scientific in the fourth quarter valued at approximately $38,000. Finally, IFP Advisors Inc purchased a new stake in shares of Semler Scientific in the fourth quarter valued at approximately $54,000. 49.37% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Separately, Lake Street Capital raised their target price on Semler Scientific from $40.00 to $71.00 and gave the company a “buy” rating in a report on Friday, January 24th.

Semler Scientific Trading Up 3.1 %

Shares of Semler Scientific stock opened at $33.33 on Friday. The company has a 50-day moving average of $35.88 and a two-hundred day moving average of $46.16. Semler Scientific, Inc. has a 12-month low of $20.88 and a 12-month high of $81.56. The stock has a market cap of $319.87 million, a PE ratio of 6.79 and a beta of 1.29.

Semler Scientific (NASDAQ:SMLR) last posted its earnings results on Tuesday, February 18th. The company reported $3.41 EPS for the quarter, topping analysts’ consensus estimates of $0.20 by $3.21. Semler Scientific had a return on equity of 50.77% and a net margin of 72.65%. The company had revenue of $12.41 million for the quarter.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.